|
1）Palevsky PM, Molitoris BA, Okusa MD, et al. Design of clinical trials in acute kidney injury: report from an NIDDK workshop on trial methodology. Clin J Am Soc Nephrol. 2012; 7: 844-50
|
|
|
|
2）Moran SM, Myers BD. Course of acute renal failure studied by a model of creatinine kinetics. Kidney Int. 1985; 27: 928-37
|
|
|
|
|
|
3）Parikh CR, Thiessen-Philbrook H, Garg AX, et al. Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clin J Am Soc Nephrol. 2013; 8: 1079-88
|
|
|
|
|
|
4）Parikh CR, Coca SG, Thiessen-Philbrook H, et al. Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol. 2011; 22: 1748-57
|
|
|
|
|
|
5）Kashani K, Al-Khafaji A, Ardiles T, et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013; 17: R25
|
|
|
|
|
|
6）Li JY, Ram G, Gast K, et al. Detection of intracellular iron by its regulatory effect. Am J Physiol Cell Physiol. 2004; 287: C1547-59
|
|
|
|
|
|
7）Mori K, Lee HT, Rapoport D, et al. Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest. 2005; 115: 610-21
|
|
|
|
|
|
8）Mishra J, Dent C, Tarabishi R, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005; 365: 1231-8
|
|
|
|
|
|
9）Kamijo－Ikemori A, Sugaya T, Matsui K, et al. Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice. Nephrology. 2011; 16: 539-44
|
|
|
|
|
|
10）Nakamura T, Sugaya T, Node K, et al. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis. 2006; 47: 439-44
|
|
|
|
|
|
11）Doi K, Negishi K, Ishizu T, et al. Evaluation of new acute kidney injury biomarkers in a mixed intensive care unit. Crit Care Med. 2011; 39: 2464-9
|
|
|
|
|
|
12）Portilla D, Dent C, Sugaya T, et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2008; 73: 465-72
|
|
|
|
|
|
13）Velez JC. The importance of the intrarenal renin-angiotensin system. Nat Clin Pract Nephrol. 2009; 5: 89-100
|
|
|
|
|
|
14）Kobori H, Alper AB Jr, Shenava R, et al. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertension. 2009; 53: 344-50
|
|
|
|
|
|
15）Mills KT, Kobori H, Hamm LL, et al. Increased urinary excretion of angiotensinogen is associated with risk of chronic kidney disease. Nephrol Dial Transplant. 2012; 27: 3176-81
|
|
|
|
|
|
16）Nishiyama A, Konishi Y, Ohashi N, et al. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant. 2011; 26: 170-7
|
|
|
|
|
|
17）Urushihara M, Nagai T, Kinoshita Y, et al. Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients. Pediatr Nephrol. 2015; 30: 975-82
|
|
|
|
|
|
18）Alge JL, Karakala N, Neely BA, et al. Association of elevated urinary concentration of renin-angiotensin system components and severe AKI. Clin J Am Soc Nephrol. 2013; 8: 2043-52
|
|
|
|
|
|
19）Alge JL, Karakala N, Neely BA, et al. Urinary angiotensinogen and risk of severe AKI. Clin J Am Soc Nephrol. 2013; 8: 184-93
|
|
|
|
|
|
20）Yang X, Chen C, Tian J, et al. Urinary angiotensinogen level predicts AKI in acute decompensated heart failure: A prospective, two-stage study. J Am Soc Nephrol. [Epub ahead of print]
|
|
|
|
|
|
21）Seo DW, Li H, Guedez L, et al. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism. Cell. 2003; 114: 171-80
|
|
|
|
|
|
22）Seo DW, Li H, Qu CK, et al. Shp-1 mediates the antiproliferative activity of tissue inhibitor of metalloproteinase-2 in human microvascular endothelial cells. J Biol Chem. 2006; 281: 3711-21
|
|
|
|
|
|
23）Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev. 1999; 20: 761-87
|
|
|
|
|
|
24）Kellum JA, Chawla LS. Cell-cycle arrest and acute kidney injury: the light and the dark sides. Nephrol Dial Transplant. [Epub ahead of print]
|
|
|
|
|
|
25）Hoste EA, McCullough PA, Kashani K, et al. Derivation and validation of cutoffs for clinical use of cell cycle arrest biomarkers. Nephrol Dial Transplant. 2014; 29: 2054-61
|
|
|
|
|
|
26）Bihorac A, Chawla LS, Shaw AD, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med.2014; 189: 932-9
|
|
|
|
|
|
27）Meersch M, Schmidt C, Van Aken H, et al . Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One. 2014; 9: e93460
|
|
|
|
|
|
28）Meersch M, Schmidt C, Van Aken H, et al. Validation of cell-cycle arrest biomarkers for acute kidney injury after pediatric cardiac surgery. PLoS One. 2014; 9: e110865
|
|
|
|
|
|
29）Gocze I, Koch M, Renner P, et al. Urinary biomarkers TIMP-2 and IGFBP7 early predict acute kidney injury after major surgery. PLoS One. 2015; 10: e0120863
|
|
|
|
|
|
30）Lo LJ, Go AS, Chertow GM, et al. Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease. Kidney Int. 2009; 76: 893-9
|
|
|
|
|
|
31）Bucaloiu ID, Kirchner HL, Norfolk ER, et al. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int. 2012; 81: 477-85
|
|
|
|
|
|
32）Ishani A, Xue JL, Himmelfarb J, et al. Acute kidney injury increases risk of ESRD among elderly. J Am Soc Nephrol. 2009; 20: 223-8
|
|
|
|
|
|
33）Chawla LS, Amdur RL, Amodeo S, et al. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney Int. 2011; 79: 1361-9
|
|
|
|
|
|
34）Thakar CV, Christianson A, Himmelfarb J, et al. Acute kidney injury episodes and chronic kidney disease risk in diabetes mellitus. Clin J Am Soc Nephrol. 2011; 6: 2567-72
|
|
|
|
|
|
35）Liu KD, Yang W, Anderson AH, et al. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease. Kidney Int. 2013; 83: 909-14
|
|
|
|
|
|
36）Coca SG, Garg AX, Thiessen-Philbrook H, et al. Urinary biomarkers of AKI and mortality 3 years after cardiac surgery. J Am Soc Nephrol. 2013; 25: 1063-71
|
|
|
|
|
|
37）Isshiki R, Doi K, Sumida M, et al. Urinary L-type fatty acid-binding protein can predict long-term renal outcome in the ICU patients. ASN abstract 2014
|
|
|
|
|
|
38）Murray PT, Mehta RL, Shaw A, et al. Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int. 2014; 85: 513-21
|
|
|
|
|